International Journal on Science and Technology

E-ISSN: 2229-7677     Impact Factor: 9.88

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 16 Issue 2 April-June 2025 Submit your research before last 3 days of June to publish your research paper in the issue of April-June.

Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry

Author(s) Sandeep Ramanamuni
Country United States
Abstract This paper highlights how digital transformation is critical in developing a competitive edge and capabilities in Contract Development and Manufacturing Organizations within the pharmaceutical industry. The fact that there is increased international demand for innovative and personalized medicines puts CDMOs under pressure to provide quicker, more efficient, and more compliant services. Such research underscores how digitalization, via technologies such as ML, the IoT, digital twins, AI, and cloud-based systems, can help CDMOs streamline their operations and improve supply chain visibility and time to market. The paper further sheds light on a digital-first mindset, cybersecurity, solid data integration, and end-to-end transparency as the bases for value delivery and sustainable growth within the pharmaceutical landscape.
Keywords digital transformation, pharmaceutical industry, CDMO, supply chain visibility, AI, IoT, digital technologies.
Field Engineering
Published In Volume 15, Issue 4, October-December 2024
Published On 2024-11-06
Cite This Digital Transformation: A Critical Component for CDMOs in the Pharmaceutical Industry - Sandeep Ramanamuni - IJSAT Volume 15, Issue 4, October-December 2024. DOI 10.71097/IJSAT.v15.i4.2834
DOI https://doi.org/10.71097/IJSAT.v15.i4.2834
Short DOI https://doi.org/g899gg

Share this